Literature DB >> 28177121

Activating transcription factor 3 (ATF3) protects against lipopolysaccharide-induced acute lung injury via inhibiting the expression of TL1A.

Lanlan Qian1, Yunfeng Zhao2, Liang Guo1, Shaoying Li3, Xueling Wu4.   

Abstract

Excessive inflammatory responses are critical in the pathogenesis of acute lung injury (ALI). Activating transcription factor 3 (ATF3) is a stress-induced transcriptional regulator that is a negative regulator of inflammatory responses. Therefore, we investigated the role and signaling pathways of ATF3 in lipopolysaccharide (LPS)-induced ALI in mice. The mouse macrophage RAW264.7 cells were cultured on HTS 24-Transwell filter plates in presence of ATF3 siRNA before exposure to LPS. ATF3 knock-out (KO) and wild type (WT) mice were challenged by intra-peritoneal injection of LPS (15 mg/kg). Gene analysis was used to analyze differential gene expression between ATF3 KO and WT mice. LPS increased the expression of ATF3 in RAW264.7 cells and in lung tissues of mice, The concentration of TNFα and IL-6 was significantly increased in ATF3 siRNA-treated RAW264.7 cells compared to control cells after LPS stimulation. The concentration of TNFα, IL-6 and IL-1β in serum and lung tissue of ATF3 KO mice was significantly increased compared to ATF3 WT mice. In addition, the lung wet/dry weight and BALF protein were significantly increased in ATF3 KO mice after LPS injection at 6, 24, and 48 hr. The survival of ATF3 KO mice significantly decreased. Differential gene analysis showed that TL1A was highly expressed in LPS-induced lung tissues of ATF3 KO mice.Moreover, ATF3 down-regulated the expression of TL1A in RAW264.7 cells and in lung tissues. These findings suggest that ATF3 protects against LPS-induced ALI via inhibiting TL1A expression.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  ATF3; RRID; TL1A; acute lung injury; inflammation

Mesh:

Substances:

Year:  2017        PMID: 28177121     DOI: 10.1002/jcp.25849

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  5 in total

1.  Ameliorative effects of silymarin on HCl-induced acute lung injury in rats; role of the Nrf-2/HO-1 pathway.

Authors:  Rasha F Ahmed; Rabab A Moussa; Reda S Eldemerdash; Mahmoud M Zakaria; Seham A Abdel-Gaber
Journal:  Iran J Basic Med Sci       Date:  2019-12       Impact factor: 2.699

2.  Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.

Authors:  Abul Bashar Mir Md Khademul Islam; Md Abdullah-Al-Kamran Khan; Rasel Ahmed; Md Sabbir Hossain; Shah Md Tamim Kabir; Md Shahidul Islam; A M A M Zonaed Siddiki
Journal:  J Transl Med       Date:  2021-01-07       Impact factor: 5.531

3.  Genome-wide expression of the residual lung reacting to experimental Pneumonectomy.

Authors:  Valerio Napolioni; Fortunato Bianconi; Rossella Potenza; Francesco M Carpi; Vienna Ludovini; Matteo Picciolini; Francesca R Tofanetti; Antonello Bufalari; Stefano Pallotti; Camilla Poggi; Marco Anile; Niccolò Daddi; Federico Venuta; Francesco Puma; Jacopo Vannucci
Journal:  BMC Genomics       Date:  2021-12-06       Impact factor: 3.969

4.  Activating transcription factor 3 inhibits angiotensin II‑induced cardiomyocyte viability and fibrosis by activating the transcription of cysteine‑rich angiogenic protein 61.

Authors:  Yu Zhang; Heming Wu; Honghui Luo; Yiqun Luo; Cong Huang
Journal:  Mol Med Rep       Date:  2022-09-14       Impact factor: 3.423

5.  Activating transcription factor 3 (ATF3) regulates cell growth, apoptosis, invasion and collagen synthesis in keloid fibroblast through transforming growth factor beta (TGF-beta)/SMAD signaling pathway.

Authors:  Xue-Ming Wang; Xiu-Mei Liu; Yuting Wang; Zhen-Yu Chen
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.